Literature DB >> 17015034

Spectral investigations of preferential solvation and solute-solvent interactions of 1,4-dimethylamino anthraquinone in CH2Cl2/C2H5OH mixtures.

M Umadevi1, A Suvitha, K Latha, Beulah J M Rajkumar, V Ramakrishnan.   

Abstract

The optical absorption and IR spectra of 1,4-dimethylamino anthraquinone (1,4-DMAAQ) in CH(2)Cl(2)/C(2)H(5)OH mixtures have been investigated. The preferential solvation of 1,4-DMAAQ in CH(2)Cl(2)/C(2)H(5)OH mixed solvents has been studied by monitoring the charge transfer band of 1,4-DMAAQ. The optical absorption spectral study indicates that 1,4-DMAAQ is preferentially solvated by CH(2)Cl(2) in CH(2)Cl(2)/C(2)H(5)OH mixtures. This can be confirmed by the observed index of preferential solvation value (delta(s1)) as well as higher mole fraction of CH(2)Cl(2) in the solvation microsphere (x(1)(L)) than in the bulk solvent (x(1)). The CH(2)Cl(2) molecules become more available to enter the solvation shell of 1,4-DMAAQ because of the hydrogen bonded clusters formed by ethanol molecules. This is also evident from the non-linear behavior of the transition energy (E(12)) as well as the absence of synergistic behavior. IR spectral studies show that the observed shifts in the nu(CO) and nu(NH) of 1,4-DMAAQ are due to the dipole-dipole interaction between the 1,4-DMAAQ and the associated ethanol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015034     DOI: 10.1016/j.saa.2006.09.008

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  Optimization in solvent selection for chlorin e6 in photodynamic therapy.

Authors:  Shubhajit Paul; Paul Wan Sia Heng; Lai Wah Chan
Journal:  J Fluoresc       Date:  2012-11-15       Impact factor: 2.217

2.  Spectral investigations of solvatochromism and preferential solvation on 1,4-dihydroxy-2,3-dimethyl-9,10-anthraquinone.

Authors:  M Umadevi; P Vanelle; T Terme; Beulah J M Rajkumar; V Ramakrishnan
Journal:  J Fluoresc       Date:  2008-07-22       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.